Cancer Biologics and Therapy,
Therapeutic Antibodies in Oncology,
 Robinson College, University of Cambridge, UK
June 29th & 30th, 2009.

The World Biopharm Forum (WBF) is pleased to inform the Development of New therapies for Cancer drug development will take place at Robinson’ College, Cambridge, UK, June 2009. This meeting will provide the current progress in innovative therapies but also focus on the future trends
The conference will bring together experts in the key disciplines of various faculties from academia and biopharmaceutical industries who are well established and actively engaged in innovative therapies for Cancer. The meeting provides opportunities for poster presentation from the speakers. The residential nature of the conference will bring strong interaction between researchers and commercial personal to develop products that can be successfully launched for cancer treatment.
 

Key Topics to be Covered include:

• Novel Cancer Target Identification and Validation

• Identification of therapeutic leads and characterisation

• Clinical experience with biologics based therapeutics in oncology including imaging technology

• Antibody distribution and dosing.

• Future advances in antibody based and novel biologics platform for oncology

Join us and hear the leading experts from industries and academia and find effective solution that can be applied in your programme

Early Bird discount available if you register and pay before 24th April.

Online payment now accepted via Paypal - Click on the button below.

Please email Dr Subramanian for more information about this conference and pre-registration.

Delegate Type Residential £610.00 Non-Residential £455.00 Early bird residential (before 24th April) £579.00 Early Bird Non-Residential (Before 24th April) £429.00

Download Programme

Previous Conferences Held

October 15-16, 2007 - New Frontiers in Nanomedicine
Hammersmith Hospital Conference Centre, London, UK
 

Nanomedicine is a newly developing field that promises to arm physicians with some of the most effective tools in medicine. The accelerating and continual progress in technology and developments in nanomedicine could dominate medical applications for years to come.

This international conference will bring together leading academics, consultants, industrialists, technologists, regulatory experts and policy makers in the field. The meeting will encourage a strong inter-disciplinary exchange in leading edge aspects of nanomedicine research and the progression into clinical practice. Participation is limited and hence academics, industry experts, clinicians and others are requested to apply to attend and submit papers or posters.

Topics include:

 

Regenerative Medicine Targeted Drug Delivery Diagnostics Drug Formulation

Regulatory and Ethical Issues Genetic and Clinical aspects Technology and Engineering Developments

 

Registration Closed

 

September 24 - 26, 2007 -  Bioseparation And Bioprocessing of Biological

QUEENS' COLLEGE, CAMBRIDGE, UK

The World Biophharm Forum (WBF) is pleased to inform that the international conference on Bioseparation and Bioprocessing of Biological, will take place at the Famous Queens College, Cambridge, UK.

The conference will bring to the forefront the up-to-date advancement in technologies and the application in streamlining the processes. The distinguished speakers will present you the effective utilisation of the technologies, process economics and avenues to rapid achieving manufacturing biological in compliance with international regulatory requirements

Join us and hear the leading experts from industries and academia and find effective solution that can be applied in your programme

March 19 – 21, 2007 – Development Of New Therapies For Cancer
NEW HALL, CAMBRIDGE, UK

The World Biopharm Forum (WBF) is pleased to inform the New Therapies for Cancer Drug Development will take place at New Hall, Cambridge, UK. This conference will build upon a dynamic programme to provide a forum for maximum exchange of information on the current advancement of new therapies for cancer. The conference will emphasise recent achievements in research and development and data rather than review alone.

The conference will include lectures from distinguished scientists from Academia and Industries who are well established in this field and actively engaged for the development of new therapies for cancer drug. The meeting will also provide poster presentations.
The residential nature of the conference will bring a strong interactive forum in bringing several experienced from academia and industries and to discuss wide range of developments including manufacturing, partnering, marketing and collaboration in drug developments. It is therefore be of great interest to scientist and business development managers who are actively engaged in this field but also to those who are interested.

Join us at Cambridge to gain current information, contacts and move the field forward to meet the new challenges.